Classic and overlap chronic graft-versus-host disease after T-replete reduced intensity conditioned sibling allograft usually starts within a year, causes prolonged morbidity but low mortality and is influenced by prophylactic methotrexate and ciclosporin dosing
Main Authors: | Medd, P, Monk, I, Danby, R, Malladi, R, Clifford, R, Collins, G, Davis, S, Ellis, A, Birks, J, Roberts, D, Hatton, C, Vyas, P, Littlewood, T, Peniket, A |
---|---|
Format: | Conference item |
Published: |
2010
|
Similar Items
-
NIH consensus chronic GvHD following T-replete reduced-intensity conditioning sibling allograft usually develops within a year, causes prolonged morbidity but low mortality and is influenced by prophylactic methotrexate dose
by: Medd, P, et al.
Published: (2010) -
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant
by: Medd, P, et al.
Published: (2011) -
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant.
by: Medd, P, et al.
Published: (2011) -
Analysis of factors affecting outcome in recipients of bone marrow transplantation for myelodysplasia; a single centre's experience over a nine year period
by: Stoll, V, et al.
Published: (2010) -
Ciclosporin A in ophthalmology: A systematic review
by: Kaberi Biswas Feroze
Published: (2019-01-01)